Did you mean: E. L. Paisano
[HTML][HTML] Testing for HCV infection: an update of guidance for clinicians and laboratorians
…, ME Brecher, WA Meyer, RL Pesano… - … and Mortality Weekly …, 2013 - ncbi.nlm.nih.gov
In the United States, an estimated 4.1 million persons have been infected with hepatitis C
virus (HCV), of whom an estimated 3.2 (95% confidence interval [CI]= 2.7–3.9) million are …
virus (HCV), of whom an estimated 3.2 (95% confidence interval [CI]= 2.7–3.9) million are …
Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014
…, EH Teshale, MA Foster, RL Pesano… - Annals of internal …, 2017 - acpjournals.org
Background: In the United States, hepatitis C virus (HCV) infection has increased among
young persons who inject drugs, but the extent of this epidemic among reproductive-aged …
young persons who inject drugs, but the extent of this epidemic among reproductive-aged …
A public health model for the molecular surveillance of HIV transmission in San Diego, California
…, L Drumright, ME Pacold, SLK Pond, RL Pesano… - Aids, 2009 - journals.lww.com
Background: Current public health efforts often use molecular technologies to identify and
contain communicable disease networks, but not for HIV. Here, we investigate how molecular …
contain communicable disease networks, but not for HIV. Here, we investigate how molecular …
[HTML][HTML] A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients
…, P Biswas, DS Chapman, Z Su, JL Platt, RL Pesano - 2012 - journals.plos.org
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected
individuals, as these agents are not effective in patients harboring CXCR4 (X4) coreceptor-using …
individuals, as these agents are not effective in patients harboring CXCR4 (X4) coreceptor-using …
The burden of hepatitis C infection–related liver fibrosis in the United States
…, MM Denniston, AE Yeo, RL Pesano… - Clinical Infectious …, 2016 - academic.oup.com
Background. Knowledge of the estimated proportion of hepatitis C virus (HCV)-infected
persons with advanced fibrosis or cirrhosis is critical to estimating healthcare needs. Methods. …
persons with advanced fibrosis or cirrhosis is critical to estimating healthcare needs. Methods. …
Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of cenicriviroc study 202, a randomized phase II trial in …
…, R Ogden, JL Platt, RL Pesano… - AIDS research and …, 2014 - liebertpub.com
Cenicriviroc is a once-daily oral CCR5/CCR2 antagonist in development for treatment of HIV
infection. CVC Study 202 (652-2-202; NCT01338883) excluded treatment-naive subjects …
infection. CVC Study 202 (652-2-202; NCT01338883) excluded treatment-naive subjects …
Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function
DD Loeb, NS Sung, RL Pesano, CJ Sexton… - Journal of …, 1990 - Am Soc Microbiol
Herpesvirus papio (HVP) is a lymphotropic virus of baboons which is related to Epstein-Barr
virus (EBV) and produces latent infection. The nucleotide sequence of the 5,775-base-pair (…
virus (EBV) and produces latent infection. The nucleotide sequence of the 5,775-base-pair (…
Testing and reporting practices for improved management of hepatitis C.
RL Pesano - Antiviral therapy, 2012 - europepmc.org
Recent advances in diagnosis and treatment are providing physicians with new options for
managing patients with chronic HCV infection. The potential of these new technologies, …
managing patients with chronic HCV infection. The potential of these new technologies, …
[HTML][HTML] Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression
…, K Anastos, M Young, WA Meyer, RL Pesano… - AIDS Research and …, 2015 - Springer
Background An HIV-1 tropism test is recommended prior to CCR5 antagonist administration
to exclude patients harboring non-R5 virus from treatment with this class of antiretrovirals. …
to exclude patients harboring non-R5 virus from treatment with this class of antiretrovirals. …
Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function
RL Pesano, JS Pagano - Journal of virology, 1986 - Am Soc Microbiol
Herpesvirus papio (HVP) and Epstein-Barr virus (EBV) are closely related biologically and
biochemically; lymphoblastoid cells infected with either virus contain episomal viral DNA. The …
biochemically; lymphoblastoid cells infected with either virus contain episomal viral DNA. The …
Did you mean to search for: E. L. Paisano